Bedfont Scientific Ltd NObreath monitor given green light for use in Clinical Practice

An independent clinical study has recently been undertaken by the Department of Pathophysiology at the National Koranyi Institute in Hungary to compare the NObreath with other commercially available Fractional Exhaled Nitric Oxide (FENO) monitors. The results released today and published in Respiratory Medicine Journal have concluded that the NObreath provides reproducible results to the two other units and is suitable for use in clinical practice.

The study carried out on 18 healthy volunteers showed that the FENO values measured with NObreath are reproducible and in good agreement with those obtained by other commercially available FENO monitors.

The full paper will be presented at the Poster Sessions at the European Respiratory Society Congress taking place between 18-22 September in Barcelona. During this Congress Bedfont Scientific Ltd will be exhibiting the NObreath monitor from Hall 2 Stand G41 where delegates will be able to have a demonstration of the monitor.

Export Manager, Claudia Cuison said “Bedfont is pleased with these results and hope to use these to further strengthen our position within the exhaled nitric oxide monitor market. We are looking forward to meeting delegates at ERS and further explaining the benefits of the NObreath monitor”

For Further Information please contact Claire Ashby on 01622 851122 or by email at Claire@bedfont.com